Skip to main content
. 2019 Sep 20;71(6):464–467. doi: 10.1016/j.ihj.2019.09.011

Table 2.

Efficacy and safety outcomes.

Outcomes No. (%)
Death from any cause 2 (5)
Normalization of RV function 32 (80)
Improvement of TR severity 36 (90)
Repeat thrombolysis 2 (5)
Surgical embolectomy 1 (2.5)
Bleeding
 Intracranial 0 (0)
 Major extracranial 0 (0)
 Minor extracranial 3 (7.5)

RV: right ventricular; TR: tricuspid regurgitation.